PubMed laboratory research record [PMID: 3741729] PubMed record related to this compound for laboratory literature review
Quick Answer: Weight loss injections can be safely used in patients with well-controlled hypothyroidism, with no absolute contraindication for standard thyroid conditions
ClinicalTrials.gov: TRIUMPH Phase 3 program trial registry entries
Conversely, a study of the GLP-1RA exenatide demonstrated that, while the drug reduced alcohol craving and consumption in obese participants, it increased heavy drinking days in lean individuals
Note that the costs, dosages, and approved uses are U.S.-based
Bank of America analysts said they now expect Novo to issue a fourth profit warning when it reports third-quarter results in November, doubting the company can meet the top end of its sales guidance